| 1 |
中华医学会心血管病学分会肺血管病学组. 急性肺栓塞诊断与治疗中国专家共识(2015)[J]. chin J Cardial, 2016, 44(3): 197-211.
|
| 2 |
Huisman MV, Klok FA. Diagnostic management of acute deep vein thrombosis and pulmonary embolism[J]. J Thromb Haemost, 2013, 11(3): 412-422.
|
| 3 |
Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43): 3033-3069, 3069a-3069k.
|
| 4 |
Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis[J]. Lancet, 2012, 379(9828): 1835-1846.
|
| 5 |
Aleman MM, Walton BL, Byrnes JR, et al. Fibrinogen and red blood cells in venous thrombosis[J]. Thromb Res, 2014, 133(Suppl 1): S38-S40.
|
| 6 |
von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo[J]. J Exp Med, 2012, 209(4): 819-835.
|
| 7 |
Darbousset R, Thomas GM, Mezouar S, et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation[J]. Blood, 2012, 120(10): 2133-2143.
|
| 8 |
Diaz JA, Alvarado CM, Wrobleski SK, et al. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse[J]. Thromb Haemost, 2013, 109(6): 1158-1169.
|
| 9 |
Alias S, Lang IM. Coagulation and the vessel wall in pulmonary embolism[J]. Pulm Circ, 2013, 3(4): 728-738.
|
| 10 |
Zapponi KC, Mazetto BM, Bittar LF, et al. Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels[J]. Thromb Res, 2014, 133(5): 736-742.
|
| 11 |
Lovren F, Verma S. Evolving role of microparticles in the pathophysiology of endothelial dysfunction[J]. Clin Chem, 2013, 59(8): 1166-1174.
|
| 12 |
Martinod K, Wagner DD. Thrombosis: tangled up in NETs[J]. Blood, 2014, 123(18): 2768-2776.
|
| 13 |
Hsieh HJ, Liu CA, Huang B, et al. Shear-induced endothelial mechanotransduction: the interplay between reactive oxygen species (ROS) and nitric oxide (NO) and the pathophysiological implications[J]. J Biomed Sci, 2014, 21: 3.
|
| 14 |
Vanhoutte PM, Shimokawa H, Feletou M, et al. Endothelial dysfunction and vascular disease - a 30th anniversary update[J]. Acta Physiol (Oxf), 2017, 219(1): 22-96..
|
| 15 |
Sun X, Belkin N, Feinberg MW. Endothelial microRNAs and atherosclerosis[J]. Curr Atheroscler Rep, 2013, 15(12): 372.
|
| 16 |
Peng J, Liu B, Ma QL, et al. Dysfunctional endothelial progenitor cells in cardiovascular diseases: role of NADPH oxidase[J]. J Cardiovasc Pharmacol, 2015, 65(1): 80-87.
|
| 17 |
Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial barrier and its abnormalities in cardiovascular disease[J]. Front Physiol, 2015, 6: 365.
|
| 18 |
Balaji S, King A, Crombleholme TM, et al. The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing[J]. Adv Wound Care (New Rochelle), 2013, 2(6): 283-295.
|
| 19 |
Alessio AM, Beltrame MP, Nascimento MC, et al. Circulating progenitor and mature endothelial cells in deep vein thrombosis[J]. Int J Med Sci, 2013, 10(12): 1746-1754.
|
| 20 |
Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism[J]. JAMA, 2014, 311(7): 717-728.
|
| 21 |
van der Hulle T, Dronkers CE, Klok FA, et al. Recent developments in the diagnosis and treatment of pulmonary embolism[J]. J Intern Med, 2016, 279(1): 16-29.
|
| 22 |
Di Nisio M, van Es N, Büller HR. et al. Deep vein thrombosis and pulmonary embolism[J]. Lancet, 2016, 388(10063): 3060-3073.
|
| 23 |
Marconi L, Carrozzi L, Aquilini F, et al. Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study[J]. Medicine (Baltimore), 2016, 95(34): e4364.
|
| 24 |
Pitonzo D, Archambault ME. Riociguat for pulmonary hypertension[J]. JAAPA, 2016, 29(6): 60-62.
|
| 25 |
Lin CP, Lin FY, Huang PH, et al. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation[J]. Biomed Res Int, 2013, 2013: 845037.
|
| 26 |
Hou X, Tong Q, Wang W, et al. Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways[J]. Life Sci, 2015, 130: 38-46.
|
| 27 |
Thitiwuthikiat P, Ii M, Saito T, et al. A vascular patch prepared from Thai silk fibroin and gelatin hydrogel incorporating simvastatin-micelles to recruit endothelial progenitor cells[J]. Tissue Eng Part A, 2015, 21(7-8): 1309-1319.
|
| 28 |
Xie L, Feng H, Li S, et al. SIRT3 mediates the antioxidant effect of hydrogen sulfide in endothelial cells[J]. Antioxid Redox Signal, 2016, 24(6): 329-343.
|
| 29 |
Cheang WS, Tian XY, Wong WT, et al. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5′ adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway[J]. Arterioscler Thromb Vasc Biol, 2014, 34(4): 830-836.
|
| 30 |
Liu HJ, Liao HH, Yang Z, et al. Peroxisome proliferator-activated receptor-γ is critical to cardiac fibrosis[J]. PPAR Res, 2016, 2016: 2198645.
|
| 31 |
Jin H, Gebska MA, Blokhin IO, et al. Endothelial PPAR-γ protects against vascular thrombosis by downregulating P-selectin expression[J]. Arterioscler Thromb Vasc Biol, 2015, 35(4): 838-844.
|
| 32 |
Nayak L, Shi H, Atkins GB, et al. The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2)[J]. Blood, 2014, 123(24): 3828-3831.
|
| 33 |
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
|
| 34 |
Schmidt M, Cannegieter SC, Johannesdottir SA, et al. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study[J]. J Thromb Haemost, 2014, 12(8): 1207-1215.
|
| 35 |
Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use[J]. Circ Res, 2012, 110(4): 624-637.
|
| 36 |
Coccheri S, Mannello F. Development and use of sulodexide in vascular diseases: implications for treatment[J]. Drug Des Devel Ther, 2013, 8: 49-65.
|